Raymond James Financial Services Advisors, Inc. Novo Cure LTD Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$40.29 - $82.51 $138,678 - $283,999	-3,442 Reduced 28.14%	8,789 $364,000
Q1 2023 Apr 14, 2023	BUY	$56.44 - $118.81 $43,458 - $91,483	770 Added 6.72%	12,231 $735,000
Q4 2022 Feb 08, 2023	BUY	$63.98 - $85.37 $45,553 - $60,783	712 Added 6.62%	11,461 $840,000
Q3 2022 Oct 25, 2022	SELL	$67.99 - $89.57 $9,450 - $12,450	-139 Reduced 1.28%	10,749 $817,000
Q2 2022 Aug 12, 2022	SELL	$56.6 - $89.9 $16,866 - $26,790	-298 Reduced 2.66%	10,888 $757,000
Q1 2022 May 11, 2022	SELL	$60.15 - $84.52 $33,383 - $46,908	-555 Reduced 4.73%	11,186 $927,000
Q4 2021 Feb 08, 2022	SELL	$75.08 - $121.99 $648,090 - $1.05 Million	-8,632 Reduced 42.37%	11,741 $882,000
Q3 2021 Nov 02, 2021	SELL	$116.17 - $194.55 $473,741 - $793,374	-4,078 Reduced 16.68%	20,373 $2.37 Million
Q2 2021 Aug 11, 2021	BUY	$130.4 - $225.58 $38,076 - $65,869	292 Added 1.21%	24,451 $5.42 Million
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $161,591 - $247,601	-1,302 Reduced 5.11%	24,159 $3.19 Million
Q4 2020 Feb 12, 2021	SELL	$112.16 - $174.14 $10,094 - $15,672	-90 Reduced 0.35%	25,461 $4.41 Million
Q3 2020 Nov 04, 2020	BUY	$58.05 - $111.31 $27,225 - $52,204	469 Added 1.87%	25,551 $2.84 Million
Q2 2020 Jul 17, 2020	SELL	$57.2 - $74.41 $430,315 - $559,786	-7,523 Reduced 23.07%	25,082 $1.49 Million
Q1 2020 Apr 21, 2020	SELL	$57.05 - $95.75 $81,524 - $136,826	-1,429 Reduced 4.2%	32,605 $2.2 Million
Q4 2019 Feb 12, 2020	BUY	$68.3 - $93.8 $224,707 - $308,602	3,290 Added 10.7%	34,034 $2.87 Million
Q3 2019 Nov 07, 2019	BUY	$61.86 - $97.8 $702,667 - $1.11 Million	11,359 Added 58.6%	30,744 $2.3 Million
Q2 2019 Aug 06, 2019	BUY	$42.22 - $63.23 $5,361 - $8,030	127 Added 0.66%	19,385 $1.23 Million
Q1 2019 May 06, 2019	SELL	$31.96 - $56.12 $55,386 - $97,255	-1,733 Reduced 8.26%	19,258 $928,000
Q4 2018 Feb 11, 2019	BUY	$28.72 - $52.63 $14,733 - $26,999	513 Added 2.51%	20,991 $703,000
Q3 2018 Nov 14, 2018	BUY	$32.0 - $52.4 $355,840 - $582,688	11,120 Added 118.83%	20,478 $1.07 Million
Q2 2018 Jul 30, 2018	BUY	$19.85 - $32.0 $185,756 - $299,456	9,358 New	9,358 $293,000

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$333 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$325 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$217 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$118 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$83.2 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.88B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account